DelveInsight’s “Cancer Anorexia Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the Cancer Anorexia, historical and forecasted epidemiology as well as the Cancer Anorexia market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
The Cancer Anorexia market report covers emerging drugs, current treatment practices, market share of the individual therapies, and current & forecasted market size from 2019 to 2032. It also evaluates the current treatment practice/algorithm, market drivers & barriers, and unmet medical needs to curate the best of the opportunities and assess the underlying potential of the market.
To Know in detail about the Cancer Anorexia market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Cancer Anorexia Market Insights
Cancer Anorexia Overview
Anorexia is a common symptom in people with cancer and a component of the cancer anorexia-cachexia syndrome (CACS).It is the lack or loss of appetite or desire to eat leading to reduced intake; however, it alone does not account for the complex alterations that characterize the CACS. The anorexia and accompanying weight loss may occur at any stage of illness with variable severity, and it may be related to several causal factors.
Some of the key facts of the Cancer Anorexia Market Report:
- The Cancer Anorexia market size was valued at USD 309.50 Million in the year 2021 and is anticipated to grow with a significant CAGR during the study period (2019-2032)
- The total incident population of anorexia by cancer types in the seven major markets was estimated to be 747,677 in 2021
- The total incident population of anorexia by cancer types in the United States was 269,338 in2021
- Anorexia is one of the top three common symptoms in patients with cancer at the end of life
- As per the studies of Muscaritoli et al., the prevalence of malnutrition in oncology (PreMiO) study which found that over 40% of cancer patients were experiencing anorexia, as reported in the VAS and FAACT questionnaire. Furthermore, more than 70% of pancreatic and gastroesophageal cancer patients, more than 60% of liver, colorectal, and GItract, and more than 40% of lung, head, and neck, and genitourinary cancer patients could be classified as cachectic, based on BMI and weight loss
- According to the article published by Currow, up to 70% of patients with advanced cancer, including those with advanced NSCLC, experience cancer anorexia/cachexia syndrome, which by definition, cannot be reversed with nutritional support alone
- Key Cancer Anorexia Companies: Helsinn Healthcare, Artelo Biosciences, NGM Biopharmaceuticals, and others
- Key Cancer Anorexia Therapies: Adlumiz, ART27.13, NGM120, and others
- The Cancer Anorexia epidemiology based on gender analyzed that Cancer Anorexia occurs in both men and women
Get a Free sample for the Cancer Anorexia Market Report -
https://www.delveinsight.com/sample-request/cancer-anorexia-market
Key benefits of the Cancer Anorexia Market report:
- Cancer Anorexia market report covers a descriptive overview and comprehensive insight of the Cancer Anorexia Epidemiology and Cancer Anorexia market in the 7MM (the United States, EU5 (Germany, Spain, France, Italy, UK) & Japan.)
- The Cancer Anorexia market report provides insights on the current and emerging therapies.
- Cancer Anorexia market report provides a global historical and forecasted market covering drug outreach in 7MM.
- The Cancer Anorexia market report offers an edge that will help develop business strategies by understanding trends shaping and driving the Cancer Anorexia market.
Download the report to understand which factors are driving Cancer Anorexia epidemiology trends @ Cancer Anorexia Epidemiological Insights
Cancer Anorexia Market
The dynamics of the Cancer Anorexia market are anticipated to change in the coming years owing to the expected launch of emerging therapies and others during the forecasted period 2019-2032.
“According to the estimates, the highest market size of Cancer Anorexia was found in theUnitedStates and the least was in Spain across the 7MM. Besides, the upcoming therapies of CancerAnorexia are expected to combat the current unmet needs faced by the patients with CancerAnorexia and add to the overall growth of the Cancer Anorexia market size”
Cancer Anorexia Epidemiology
The epidemiology section provides insights into the historical, current, and forecasted epidemiology trends in the seven major countries (7MM) from 2019 to 2032. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides a detailed analysis of the diagnosed patient pool and future trends.
Cancer Anorexia Epidemiology Segmentation:
The Cancer Anorexia market report proffers epidemiological analysis for the study period 2019–2032 in the 7MM segmented into:
- Total Prevalence of Cancer Anorexia
- Prevalent Cases of Cancer Anorexia by severity
- Gender-specific Prevalence of Cancer Anorexia
- Diagnosed Cases of Episodic and Chronic Cancer Anorexia
Cancer Anorexia Drugs Uptake and Pipeline Development Activities
The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Cancer Anorexia market or expected to get launched during the study period. The analysis covers Cancer Anorexia market uptake by drugs, patient uptake by therapies, and sales of each drug.
Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share.
The report also covers the Cancer Anorexia Pipeline Development Activities. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyzes recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.
Discover more about therapies set to grab major Cancer Anorexia market share @ Cancer Anorexia market forecast
Cancer Anorexia Therapies and Key Companies
- Adlumiz: Helsinn Healthcare
- ART27.13: Artelo Biosciences
- NGM120: NGM Biopharmaceuticals
Cancer Anorexia Market Drivers
- An increasing population of cancer patients with anorexia in the 7MM
- Scope of upcoming therapies
- Opportunity for novel treatments
- Presence of effective disease scoring system
Scope of the Cancer Anorexia Market Report
- Study Period: 2019–2032
- Coverage: 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan]
- Key Cancer Anorexia Companies: Helsinn Healthcare, Artelo Biosciences, NGM Biopharmaceuticals, and others
- Key Cancer Anorexia Therapies: Adlumiz, ART27.13, NGM120, and others
- Cancer Anorexia Therapeutic Assessment: Cancer Anorexia current marketed and Cancer Anorexia emerging therapies
- Cancer Anorexia Market Dynamics: Cancer Anorexia market drivers and Cancer Anorexia market barriers
- Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter’s five forces, BCG Matrix, Market entry strategies
- Cancer Anorexia Unmet Needs, KOL’s views, Analyst’s views, Cancer Anorexia Market Access and Reimbursement
Cancer Anorexia Market Barriers
- Disease burden and impact on the quality of life
- Lack of knowledge about the condition
- The high mortality rate in cancer patients due to anorexia
Table of Contents
1. Cancer Anorexia Market Report Introduction
2. Executive Summary for Cancer Anorexia
3. SWOT analysis of Cancer Anorexia
4. Cancer Anorexia Patient Share (%) Overview at a Glance
5. Cancer Anorexia Market Overview at a Glance
6. Cancer Anorexia Disease Background and Overview
7. Cancer Anorexia Epidemiology and Patient Population
8. Country-Specific Patient Population of Cancer Anorexia
9. Cancer Anorexia Current Treatment and Medical Practices
10. Cancer Anorexia Unmet Needs
11. Cancer Anorexia Emerging Therapies
12. Cancer Anorexia Market Outlook
13. Country-Wise Cancer Anorexia Market Analysis (2019–2032)
14. Cancer Anorexia Market Access and Reimbursement of Therapies
15. Cancer Anorexia Market Drivers
16. Cancer Anorexia Market Barriers
17. Cancer Anorexia Appendix
18. Cancer Anorexia Report Methodology
19. DelveInsight Capabilities
20. Disclaimer
21. About DelveInsight
To know more about Cancer Anorexia treatment, visit @ Cancer Anorexia Medications
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Gaurav Bora
Email:Send Email
Phone: 9193216187
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: Nevada
Country: United States
Website: https://www.delveinsight.com/consulting
